Ana Vitoria Sena Gouveia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Vitoria Sena Gouveia has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Luiz Boechat
Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas , Manaus, Amazonas
1 shared publication Aya Sadahiro
Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas , Manaus, Amazonas
1 shared publication- Eryck Gabriel Rodrigues Silva
Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas , Manaus, Amazonas
1 shared publication - Josué Lacerda de Souza
Programa de Pós-Graduação em Biodiversidade e Biotecnologia da Amazonia Legal (Rede Bionorte), Universidade do Estado do Amazonas , Manaus
1 shared publication - José Pereira de Moura Neto
Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas , Manaus, Amazonas
1 shared publication Júlia da Costa Torres
Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas , Manaus, Amazonas
1 shared publication
Latest Publications
- 30 March 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (3) , 439-448
Contrasting Genetic Effects Within STAT4 Define Susceptibility and Protection in Leishmania guyanensis Cutaneous Leishmaniasis
Background: Leishmania guyanensis-associated cutaneous leishmaniasis (CL) is endemic in the Brazilian Amazonas. Despite similar exposure to the pathogen in endemic areas, only a subset of individuals develops disease, suggesting host-genetic control. STAT4 triggers interleukin 12 (IL-12)–dependent Th1 differentiation and interferon-γ (IFN-γ) production, essential for macrophage-mediated parasite clearance. Methods: We performed a case-control study of 802 patients with L. guyanensis CL and 842 endemic controls (ECs). Eleven STAT4 variants (10 SNVs and 1 insertion/deletion) were genotyped. Associations were assessed using logistic regression adjusted for age and sex across multiple genetic models, with haplotype analysis adjusted for age and sex via omnibus and likelihood ratio tests. Results: Two SNVs exerted contrasting associations: the rs1031509 T allele increased susceptibility (adjusted odds ratio [ORadj] = 1.5; 95% CI, 1.3–1.7; adjusted P value, Bonferroni correction [Padj-B] = 1.3 × 10−5), while the rs6434435 A allele conferred protection (ORadj = 0.56; 95% CI, .43−.68; Padj-B = 2.6 × 10−8). Omnibus haplotype analysis revealed significant global differences in haplotype distribution between L. guyanensis CL and ECs (omnibus unadjusted χ2 = 55.65, df = 13, P = 3.11 × 10−7; likelihood ratio test χ2 = 67.81, df = 13, P = 2.02 × 10−9), with a specific high-risk combination (AIGAAAGCTGC) associated with a 9-fold increase in susceptibility (adjusted OR = 9.12; 95% CI, 4.22–19.70; P = 1.9 × 10−8; FDR q = 2.4 × 10−7). Genotype-cytokines analyses revealed that carriers of the protected rs6434435 A allele had significantly higher TNF-α plasma levels under dominant model (+40.2%, FDR adjusted P = .026) and additive model, with a nominal trend toward elevated IFN-γ. Conclusions: Haplotypic variation at this locus significantly shapes host inflammatory responses, highlighting STAT4 as a key immunogenetic determinant of resistance to Leishmania infection.
- 30 March 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 234 (3) , 439-448
Contrasting Genetic Effects Within STAT4 Define Susceptibility and Protection in Leishmania guyanensis Cutaneous Leishmaniasis
Background: Leishmania guyanensis-associated cutaneous leishmaniasis (CL) is endemic in the Brazilian Amazonas. Despite similar exposure to the pathogen in endemic areas, only a subset of individuals develops disease, suggesting host-genetic control. STAT4 triggers interleukin 12 (IL-12)–dependent Th1 differentiation and interferon-γ (IFN-γ) production, essential for macrophage-mediated parasite clearance. Methods: We performed a case-control study of 802 patients with L. guyanensis CL and 842 endemic controls (ECs). Eleven STAT4 variants (10 SNVs and 1 insertion/deletion) were genotyped. Associations were assessed using logistic regression adjusted for age and sex across multiple genetic models, with haplotype analysis adjusted for age and sex via omnibus and likelihood ratio tests. Results: Two SNVs exerted contrasting associations: the rs1031509 T allele increased susceptibility (adjusted odds ratio [ORadj] = 1.5; 95% CI, 1.3–1.7; adjusted P value, Bonferroni correction [Padj-B] = 1.3 × 10−5), while the rs6434435 A allele conferred protection (ORadj = 0.56; 95% CI, .43−.68; Padj-B = 2.6 × 10−8). Omnibus haplotype analysis revealed significant global differences in haplotype distribution between L. guyanensis CL and ECs (omnibus unadjusted χ2 = 55.65, df = 13, P = 3.11 × 10−7; likelihood ratio test χ2 = 67.81, df = 13, P = 2.02 × 10−9), with a specific high-risk combination (AIGAAAGCTGC) associated with a 9-fold increase in susceptibility (adjusted OR = 9.12; 95% CI, 4.22–19.70; P = 1.9 × 10−8; FDR q = 2.4 × 10−7). Genotype-cytokines analyses revealed that carriers of the protected rs6434435 A allele had significantly higher TNF-α plasma levels under dominant model (+40.2%, FDR adjusted P = .026) and additive model, with a nominal trend toward elevated IFN-γ. Conclusions: Haplotypic variation at this locus significantly shapes host inflammatory responses, highlighting STAT4 as a key immunogenetic determinant of resistance to Leishmania infection.